Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Karisma Patel"'
Publikováno v:
mSphere, Vol 9, Iss 3 (2024)
ABSTRACTOver a 6-month span, three patients under 5 years old with cutaneous leishmaniasis presented to the Pediatric Infectious Diseases Clinic at the University of Texas Southwestern Medical Center/Children’s Health Dallas. None had traveled outs
Externí odkaz:
https://doaj.org/article/cea0170a7ced4a5f88868d1b5a69d507
Autor:
Gilad Sherman, Gabriella S Lamb, Tanvi S Sharma, Elizabeth C Lloyd, Jerod Nagel, Nada N Dandam, Carlos R Oliveira, Hassan S Sheikha, Brenda I Anosike, Philip Lee, Surabhi B Vora, Karisma Patel, Paul K Sue, Beenish Rubbab, April M Yarbrough, Lakshmi Ganapathi, Mari M Nakamura
Publikováno v:
Journal of the Pediatric Infectious Diseases Society. 12:152-155
Monoclonal antibodies for COVID-19 are authorized in high-risk patients aged ≥12 years, but evidence in pediatric patients is limited. In our cohort of 142 patients treated at seven pediatric hospitals between 12/1/20 and 7/31/21, 9% developed adve
Autor:
Maria J. Sanchez, Karisma Patel, Eduardo A. Lindsay, Naureen G. Tareen, Chanhee Jo, Lawson A. Copley, Paul K. Sue
Publikováno v:
The Pediatric infectious disease journal. 41(9)
Staphylococcus aureus bacteremia (SAB) is a frequent complication of acute hematogenous osteomyelitis (AHO) in children, but data on the optimal duration of parenteral antibiotics prior to transition to oral antibiotics remains sparse. We examined cl
Autor:
Vineeta Mittal, Archana Dhar, Alan C Farrow-Gillespie, Paul K. Sue, Craig J. Huang, Ayesha Zia, Karisma Patel, Lawson A B Copley, Matthew R. Hammer
Publikováno v:
JBJS reviews. 8(3)
A team approach is optimal in the evaluation and treatment of musculoskeletal infection in pediatric patients given the complexity and uncertainty with which such infections manifest and progress, particularly among severely ill children. The team ap
Autor:
Jennifer L. Goldman, Karisma Patel
Publikováno v:
The Journal of Clinical Pharmacology. 56:1060-1075
Fluoroquinolones are highly effective antibiotics with many desirable pharmacokinetic and pharmacodynamic properties including high bioavailability, large volume of distribution, and a broad spectrum of antimicrobial activity. Despite their attractiv
Autor:
Karisma Patel, Meredith Stocks, Patricia Jackson, Aimee Dassner, Naomi J. Winick, Laura M. Filkins, Michael E. Sebert, Paul K. Sue
Publikováno v:
American Journal of Infection Control. 48:S16
Background Carbapenem-resistant Enterobacteriaceae (CRE) infections are associated with high mortality worldwide, primarily due to delayed administration and limited availability of effective antibiotics. Some CRE produce carbapenemases, which confer
Autor:
Paul K. Sue, Karisma Patel, Chan-Hee Jo, Maria J Sanchez, Eduardo A. Lindsay, Naureen Tareen, Lawson A B Copley
Publikováno v:
Open Forum Infectious Diseases
Background There is limited evidence-based guidance for the treatment of children with acute hematogenous osteomyelitis (AHO) and concurrent Staphylococcus aureus bacteremia (SAB). Current guidelines emphasize the need for parenteral antibiotics in t
Publikováno v:
Pediatric Drugs. 17:97-103
Sixty years later, the question that still remains is how to appropriately utilize vancomycin in the pediatric population. The Infectious Diseases Society of America published guidelines in 2011 that provide guidance for dosing and monitoring of vanc
Autor:
Paul K. Sue, Karisma Patel, Lawson A B Copley, Maria J Sanchez, Eduardo A. Lindsay, Naureen Tareen
Publikováno v:
Open Forum Infectious Diseases
Background Current guidelines recommend the use of parenteral vancomycin for children with acute hematogenous osteomyelitis and concurrent Staphylococcus aureus bacteremia (SAB) due to Methicillin-Resistant Staphylococcus aureus (MRSA), despite vanco
Autor:
Russell J. McCulloh, Karisma Patel
Publikováno v:
Current infectious disease reports. 18(5)
Community-acquired pneumonia (CAP) is the most common acute infectious cause of death in children worldwide. Consequently, research into the epidemiology, diagnosis, treatment, and prevention of pediatric CAP spans the translational research spectrum